These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4343408)

  • 21. Neutralizing antibodies to simian papovavirus SA12 in Old World primates in laboratory colonies: high prevalence in baboons.
    Braun L; Kalter SS; Yakovleva LA; Kaschula VR; Shah KV
    J Med Primatol; 1980; 9(4):240-6. PubMed ID: 6252324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients.
    Chou SW
    J Infect Dis; 1989 Jul; 160(1):16-21. PubMed ID: 2543709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytomegalovirus complement fixation antibodies in the umbilical cord blood of newborns and their mothers].
    Kaynar V; Cengiz L
    Mikrobiyol Bul; 1981 Jan; 15(1):35-9. PubMed ID: 6300617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotavirus antibody assays on monkey sera: a comparison of enzyme immunoassay with neutralization and complement-fixation tests.
    Stuker G; Schmidt NJ; Forghani B; Holmberg CA; Henrickson RV; Anderson JH
    Am J Vet Res; 1979 Nov; 40(11):1620-3. PubMed ID: 230760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus complement-fixing IgM antibody.
    Booth JC; Hannington G; Tryhorn Y; Stern H
    J Med Virol; 1980; 5(3):183-93. PubMed ID: 6262447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of gel precipitin test in the diagnosis of cytomegalovirus infections.
    Fioretti A; Pollini C
    Acta Virol; 1978 Jan; 22(1):66-9. PubMed ID: 25010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions.
    Nielsen CM; Hansen K; Andersen HM; Gerstoft J; Vestergaard BF
    J Med Virol; 1987 May; 22(1):67-76. PubMed ID: 3035081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
    Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
    Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of human cytomegalovirus strain variations by kinetic neutralization tests.
    Andersen HK
    Arch Gesamte Virusforsch; 1972; 38(4):297-305. PubMed ID: 4343371
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
    Yue Y; Zhou SS; Barry PA
    J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgM antibodies to cytomegalovirus during pregnancy.
    Kampa D; Schmitz H; Doerr HW; Luthardt T; Hillemanns HG; Wurtele A
    Arch Virol; 1977; 53(3):177-84. PubMed ID: 193462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological study of cytomegalovirus complement-fixing antibodies in the population of the CSR.
    Seeman J
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(4):489-96. PubMed ID: 192796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital cytomegalovirus infection.
    Stagno S; Reynolds DW; Huang ES; Thames SD; Smith RJ; Alford CA
    N Engl J Med; 1977 Jun; 296(22):1254-8. PubMed ID: 193004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization of cytomegalovirus virions: the role of complement.
    Spiller OB; Hanna SM; Devine DV; Tufaro F
    J Infect Dis; 1997 Aug; 176(2):339-47. PubMed ID: 9237698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strain-specific neutralization of human cytomegalovirus isolates by human sera.
    Klein M; Schoppel K; Amvrossiadis N; Mach M
    J Virol; 1999 Feb; 73(2):878-86. PubMed ID: 9882288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological evidence of infection with Tana and Yaba pox viruses among several species of monkey.
    Downie AW
    J Hyg (Lond); 1974 Apr; 72(2):245-50. PubMed ID: 4362411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection.
    Sarov I; Siqueira-Linhares M; Chardonnet Y; Levy E; Aymard M; Bosshard S; Nord E; Revillard JP
    Intervirology; 1981; 15(4):228-34. PubMed ID: 6271707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of anti-complement immunofluorescence test in cytomegalovirus infection.
    Rao N; Waruszewski DT; Armstrong JA; Atchison RW; Ho M
    J Clin Microbiol; 1977 Dec; 6(6):633-8. PubMed ID: 201665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.